SCHEMBL2200757

SCHEMBL2200757

CC(C)OC(=O)C[C@H](N)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.52
GRIK1 P39086 10/20 0.50
GRIK2 Q13002 6/20 0.50
SLC1A3 P43003 4/20 0.47
SLC1A2 P43004 4/20 0.47
SLC1A1 P43005 4/20 0.47
GRIA4 P48058 3/20 0.46
GRIK3 Q13003 3/20 0.46
GRIK5 Q16478 3/20 0.46
GRIA2 P42262 2/20 0.46
GRIA1 P42261 1/20 0.46
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP3 P08254 1/20 0.44
MMP9 P14780 1/20 0.44
MMP13 P45452 1/20 0.44
GRM1 Q13255 1/20 0.43
GRM2 Q14416 1/20 0.43
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14043512 1.00 SLC7A5 (0.52) SLC7A5GRIK1GRIK2SLC1A3SLC1A2
SCHEMBL17199753 0.85 SLC7A5 (0.50) SLC7A5GRIK1GRIK2SLC1A3SLC1A2
SCHEMBL27953785 0.85 SLC7A5 (0.39) SLC7A5GRIK1GRIK2SLC1A3SLC1A2
SCHEMBL6435729 0.83 LMNA (0.39) SLC7A5GRIK1GRIK2MMP1MMP2
SCHEMBL9621547 0.83 LMNA (0.39) SLC7A5GRIK1GRIK2MMP1MMP2
SCHEMBL6435735 0.83 LMNA (0.39) SLC7A5GRIK1GRIK2MMP1MMP2
SCHEMBL25491140 0.81 SLC7A5 (0.42) SLC7A5GRIK1GRIK2SLC1A3SLC1A2
Hydrochloric Acid SCHEMBL6946979 0.81 LMNA (0.38) SLC7A5GRIK1GRIK2MMP1MMP2
SCHEMBL9017502 0.80 NOS3 (0.44) SLC7A5GRIK1GRIK2SLC1A3SLC1A2
SCHEMBL17525660 0.79 LMNA (0.43) MMP1MMP2MMP3MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478324-B Active compound and application thereof in side chain carboxyl compound protection 上海嘉莱多生物技术有限责任公司 2023-07-07 CN disclosed
WO-2023083291-A1 DERIVATIVE OF ASPARTIC ACID AND USE THEREOF IN TREATMENT OF METABOLIC DISEASES SUCH AS HEPATIC FIBROSIS AND NON-ALCOHOLIC HEPATITIS 深圳利沃生物医药科技有限公司 2023-05-19 WO disclosed
CN-114478324-A Active compound and application thereof in side chain carboxyl compound protection 上海嘉莱多生物技术有限责任公司 2022-05-13 CN disclosed
CN-104169322-A Method for producing ring-opening metathesis polymer hydride, and resin composition ZEON CORP 2014-11-26 CN disclosed
CN-101495571-B Thermoplastic resin composition and molded body thereof MITSUI CHEMICALS, INC. (JP) 2012-02-08 CN disclosed
EP-2345733-A1 PROCESS FOR PRODUCING N-PROTECTED AMINO ACID Kaneka Corporation (JP) 2011-07-20 EP disclosed
US-7919454-B2 Methods of treating using conjugates transported by a PEPT2 transporter XENOPORT, INC. (US) 2011-04-05 US disclosed
CN-101495571-A Thermoplastic resin composition and molded body thereof MITSUI CHEMICALS INC (JP) 2009-07-29 CN disclosed
EP-1135398-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION Monsanto Technology LLC (US) 2001-09-26 EP disclosed
US-6218563-B1 Cyanophosphonamides and method for preparation MONSANTO COMPANY 2001-04-17 US disclosed
WO-2000032611-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION MONSANTO TECHNOLOGY LLC (US) 2000-06-08 WO disclosed